While FASN may be dispensable at high E:T ratios, at physiologically relevant low E:T ratios, the FASN lipogenic machinery appears to be essential for protecting HER2 + /PD-L1+ breast cancer cells from elimination by T-cells. The gene discussed is CD274; the disease is breast carcinoma.